The Petri Dish: Roche, Blueprint end lung cancer collab; Atea scraps dengue drug
Atea Pharmaceuticals is no longer working on a drug for dengue fever, citing a variety of challenges to running clinical studies.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Rowan Walrath Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Dengue Fever | Health Management | Lung Cancer | Study